JO
RVPH

John Overdeck’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

John Overdeck’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,715
Closed -$7.82K – 5377
2026
Q1 		$7.82K Buy
10,715
+10,022
+1,446% +$45.6K ﹤0.01% 4536
2025
Q4 		$3.87K Sell
693
-396
-36% -$4.4K ﹤0.01% 4038
2025
Q3 		$8.03K Sell
1,089
-323
-23% -$2.75K ﹤0.01% 3624
2025
Q2 		$10.8K Buy
1,412
+378
+37% +$5.89K ﹤0.01% 3137
2025
Q1 		$19.7K Sell
1,034
-24
-2% -$754 ﹤0.01% 3107
2024
Q4 		$38.3K Sell
1,058
-10
-0.9% -$278 ﹤0.01% 3065
2024
Q3 		$30.8K Sell
1,068
-485
-31% -$10.8K ﹤0.01% 3000
2024
Q2 		$39.8K Buy
+1,553
New +$70.6K ﹤0.01% 2901
2024
Q1 		– Sell
-2,080
Closed -$214K – 3338
2023
Q4 		$214K Buy
2,080
+1,315
+172% +$118K ﹤0.01% 2814
2023
Q3 		$74.7K Sell
765
-51
-6% -$4.75K ﹤0.01% 2774
2023
Q2 		$95.7K Sell
816
-4
-0.5% -$507 ﹤0.01% 2761
2023
Q1 		$68.7K Sell
820
-1,532
-65% -$134K ﹤0.01% 2715
2022
Q4 		$200K Buy
+2,352
New +$179K ﹤0.01% 2397

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

John Overdeck's RVPH Position: Q2 2026 in Review

John Overdeck sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 10,715 shares — an estimated $7.82K sold.

John Overdeck first reported a position in RVPH in Q4 2022 and held it in 13 quarters. The position peaked at $214K in Q4 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • John Overdeck reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 10,715 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $7.82K.
  • John Overdeck first reported a position in REVIVA PHARMA HLDGS INC in Q4 2022 and held it in 13 quarters.
  • John Overdeck's REVIVA PHARMA HLDGS INC position peaked at $214K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.